135 related articles for article (PubMed ID: 6794605)
21. Effects of mitomycin C on metabolism in a rat liver preparation.
Kimpel DL; Sagone AL
Biochem Pharmacol; 1984 Nov; 33(21):3479-84. PubMed ID: 6437409
[TBL] [Abstract][Full Text] [Related]
22. Conversion of mitomycin C to 2,7-diaminomitosene and 10-decarbamoyl 2,7-diaminomitosene in tumour tissue in vivo.
Chirrey L; Cummings J; Halbert GW; Smyth JF
Cancer Chemother Pharmacol; 1995; 35(4):318-22. PubMed ID: 7828274
[TBL] [Abstract][Full Text] [Related]
23. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
[TBL] [Abstract][Full Text] [Related]
24. Mitomycin antibiotic reductive potential and related pharmacological activities.
Pan SS; Gonzalez H
Mol Pharmacol; 1990 Jun; 37(6):966-70. PubMed ID: 2113607
[TBL] [Abstract][Full Text] [Related]
25. Chemical modification of DNA with muta-carcinogens. III. Reductive alkylation of DNA with mitomycin C.
Hashimoto Y; Shudo K
Environ Health Perspect; 1985 Oct; 62():219-22. PubMed ID: 3936706
[TBL] [Abstract][Full Text] [Related]
26. Determination of mitomycin C, 2,7-diaminomitosene, 1,2-cis- and 1,2-trans-1-hydroxy-2,7-diaminomitosene in tumour tissue by high-performance liquid chromatography.
Cummings J; Chirrey L; Willmott N; Halbert GW; Smyth JF
J Chromatogr; 1993 Jan; 612(1):105-13. PubMed ID: 8454690
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of monofunctional and bifunctional alkylation of DNA by mitomycin C.
Tomasz M; Chawla AK; Lipman R
Biochemistry; 1988 May; 27(9):3182-7. PubMed ID: 3134045
[TBL] [Abstract][Full Text] [Related]
28. Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C.
Palom Y; Belcourt MF; Kumar GS; Arai H; Kasai M; Sartorelli AC; Rockwell S; Tomasz M
Oncol Res; 1998; 10(10):509-21. PubMed ID: 10338154
[TBL] [Abstract][Full Text] [Related]
29. Microsomal superoxide anion production and NADPH-oxidation in a series of 22 aziridinylbenzoquinones.
Prins B; Koster AS; Verboom W; Reinhoudt DN
Biochem Pharmacol; 1989 Nov; 38(21):3753-7. PubMed ID: 2557029
[TBL] [Abstract][Full Text] [Related]
30. Metabolites and DNA adduct formation from flavoenzyme-activated porfiromycin.
Pan SS; Iracki T
Mol Pharmacol; 1988 Aug; 34(2):223-8. PubMed ID: 3412325
[TBL] [Abstract][Full Text] [Related]
31. Formation of reductive metabolite, 2-sulfamoylacetylphenol, from zonisamide in rat liver microsomes.
Nakasa H; Komiya M; Ohmori S; Kitada M; Rikihisa T; Kanakubo Y
Res Commun Chem Pathol Pharmacol; 1992 Jul; 77(1):31-41. PubMed ID: 1439179
[TBL] [Abstract][Full Text] [Related]
32. Circumvention of deficient activation in mitomycin C-resistant human colonic carcinoma cells by the mitomycin C analogue BMY25282.
Chakrabarty S; Danels YJ; Long BH; Willson JK; Brattain MG
Cancer Res; 1986 Jul; 46(7):3456-8. PubMed ID: 3754788
[TBL] [Abstract][Full Text] [Related]
33. Solution structure of a guanine-N7-linked complex of the mitomycin C metabolite 2,7-diaminomitosene and DNA. Basis of sequence selectivity.
Subramaniam G; Paz MM; Suresh Kumar G; Das A; Palom Y; Clement CC; Patel DJ; Tomasz M
Biochemistry; 2001 Sep; 40(35):10473-84. PubMed ID: 11523988
[TBL] [Abstract][Full Text] [Related]
34. Reduction of chromium(VI) to chromium(V) by rat liver cytosolic and microsomal fractions: is DT-diaphorase involved?
Aiyar J; De Flora S; Wetterhahn KE
Carcinogenesis; 1992 Jul; 13(7):1159-66. PubMed ID: 1379126
[TBL] [Abstract][Full Text] [Related]
35. Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.
Pan SS; Yu F; Hipsher C
Mol Pharmacol; 1993 Jun; 43(6):870-7. PubMed ID: 8316219
[TBL] [Abstract][Full Text] [Related]
36. Noncovalent binding of a mitomycin C metabolite, 2,7-diaminomitosene, to duplex DNA.
Peterson DM; Fisher J; Beall HD; Ross D
Cancer Lett; 1995 Apr; 90(2):133-8. PubMed ID: 7736448
[TBL] [Abstract][Full Text] [Related]
37. Alkylation of calf thymus DNA with reductively activated mitomycin C.
Hashimoto Y; Shudo K; Okamoto T
Nucleic Acids Symp Ser; 1981; (10):217-20. PubMed ID: 6796944
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the effect of oxygen exposure on human liver microsomal metabolism of mitomycin C in the presence of glutathione using liquid chromatography-quadrupole time of flight mass spectrometry.
Lang W; Caldwell GW; Masucci JA
Anal Biochem; 2005 Aug; 343(2):268-76. PubMed ID: 16005424
[TBL] [Abstract][Full Text] [Related]
39. Structural and function modification of DNA by mitomycin C. Mechanism of the DNA sequence specificity of mitomycins.
Gargiulo D; Kumar GS; Musser SS; Tomasz M
Nucleic Acids Symp Ser; 1995; (34):169-70. PubMed ID: 8841606
[TBL] [Abstract][Full Text] [Related]
40. Free-radical formation by mitomycin C and its novel analogs in cardiac microsomes and the perfused rat heart.
Politi PM; Rajagopalan S; Sinha BK
Biochim Biophys Acta; 1989 Sep; 992(3):341-8. PubMed ID: 2550081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
